Pascale Abrams

Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach

Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer

Rapid and sustained reduction of serum growth hormone and insulin-like growth factor-1 in patients with acromegaly receiving lanreotide Autogel® therapy: a randomized, placebo-controlled, multicenter study with a 52 week open extension

Pegvisomant and cabergoline combination therapy in acromegaly

Home administration of lanreotide Autogel^® by patients with acromegaly, or their partners, is safe and effective

A composite immune signature parallels disease progression across T1D subjects

Long-acting insulin analogues versus NPH human insulin in type 2 diabetes

Visfatin: the missing link between intra-abdominal obesity and diabetes?

Acromegaly: An Endocrine Society Clinical Practice Guideline

Red meat consumption and risk of type 2 diabetes: 3 cohorts of US adults and an updated meta-analysis

Type 2 diabetes

A review of human and analogue insulin trials

Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Insulin detemir: from concept to clinical experience

Drug Removal by Plasmapheresis: An Evidence‐Based Review

The role of iron in type 2 diabetes in humans

Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles

Activation of Oxidative Stress by Acute Glucose Fluctuations Compared With Sustained Chronic Hyperglycemia in Patients With Type 2 Diabetes

Thyroid Storm Due to Inappropriate Administration of a Compounded Thyroid Hormone Preparation Successfully Treated with Plasmapheresis

Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

Continuous Glucose Monitoring

A Critical Analysis of Clinically Available Somatostatin Analog Formulations for Therapy of Acromegaly

Comparison of a Needle-Type and a Microdialysis Continuous Glucose Monitor in Type 1 Diabetic Patients

Myocardial Fatty Acid Metabolism in Health and Disease

A 26-Week, Randomized, Parallel, Treat-to-Target Trial Comparing Insulin Detemir With NPH Insulin as Add-On Therapy to Oral Glucose-Lowering Drugs in Insulin-Naive People With Type 2 Diabetes

Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Understanding how pharmacokinetic and pharmacodynamic differences of basal analog insulins influence clinical practice

Sensitive detection of multiple islet autoantibodies in type 1 diabetes using small sample volumes by agglutination-PCR

Electrochemical Glucose Sensors and Their Applications in Diabetes Management

Severe Hyperthyroidism Complicated by Agranulocytosis Treated with Therapeutic Plasma Exchange: Case Report and Review of the Literature

Prediction of Impending Type 1 Diabetes through Automated Dual-Label Measurement of Proinsulin:C-Peptide Ratio

Health risks of lipodystrophy and abdominal fat accumulation: therapeutic possibilities with leptin and human growth hormone

Postprandial glucose monitoring in type 1 diabetes mellitus: use of a continuous subcutaneous monitoring device

Optimalization and cost management of lanreotide-Autogel therapy in acromegaly

Remission of acromegaly following long-term therapy with cabergoline: report of two cases

Impact of diabetes mellitus on the relationships between iron‐, inflammatory‐ and oxidative stress status

Plasmapheresis as effective treatment for thyrotoxic storm after sleeve pneumonectomy

Efficacy and tolerability of lanreotide Autogel therapy in acromegalic patients previously treated with octreotide LAR

Insulin Detemir Offers Improved Glycemic Control Compared With NPH Insulin in People With Type 1 Diabetes